OTCMKTS:MKGAY Merck KGaA (MKGAY) Stock Price, News & Analysis $38.36 0.00 (0.00%) (As of 08/1/2017) Add Compare Share Share Stock Analysis Stock Analysis About Merck KGaA Stock (OTCMKTS:MKGAY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Merck KGaA alerts:Sign Up Key Stats Today's Range$38.36▼$38.3650-Day Range$38.36▼$38.3652-Week Range$32.53▼$42.02VolumeN/AAverage Volume6,872 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMerck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.Read More… The #1 ETF for monthly income (Ad)We just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could start collecting it if you act by December 19th.Click here to get the full story >> Receive MKGAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address MKGAY Stock News HeadlinesMerck in Cancer Licensing Pact With LaNova MedicinesNovember 14, 2024 | marketwatch.comMerck KGaA continues focus on strengthening pipeline with external innovation, says CFO on drug trialsNovember 14, 2024 | msn.comUrgent: Monday is the last day to start collecting up to $4,243 in monthly dividendsYou could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. Registration to collect your first payout closes this week, so you are advised to sign up today.November 22, 2024 | Investors Alley (Ad)Germany’s Merck Expects Sales at Lower End of Outlook Range After Third-Quarter MissNovember 14, 2024 | wsj.comMerck’s Q3 earnings beat estimates, but company lowers guidance and stock dipsOctober 31, 2024 | marketwatch.comMerck sees Gardasil China woes carrying into 2025October 31, 2024 | msn.comLife science business investing $76M, adding 170 jobs at St. Louis facilityOctober 29, 2024 | bizjournals.comGermany's Merck open to more M&A for its Life Science divisionOctober 17, 2024 | msn.comSee More Headlines MKGAY Stock Analysis - Frequently Asked Questions How have MKGAY shares performed this year? Merck KGaA's stock was trading at $38.36 at the beginning of 2024. Since then, MKGAY stock has increased by 0.0% and is now trading at $38.36. View the best growth stocks for 2024 here. How do I buy shares of Merck KGaA? Shares of MKGAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceuticals - Major Sub-IndustryN/A Current SymbolOTCMKTS:MKGAY CUSIPN/A CIKN/A WebN/A Phone496151720FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:MKGAY) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.